Understanding of Post Covid Mucormycosis through the Lens of Ayurveda

Authors

  • Anupama M Bathe
  • Harsha Thanvi
  • Digambar Dipankar
  • Leena Jungade
  • Jibi Varghese
  • Pallavi Mane

DOI:

https://doi.org/10.47552/ijam.v13i2.2659

Keywords:

Abhishangaj vyadhi, Anukta Vyadhi, Mucormycosis, RaktaPitta Pradhan Tridoshaj Vyadhi

Abstract

Mucormycosis is fungal disease caused by fungus Mucor. It has been seen as a life-threatening complication of disease Covid-19. It has 70 times higher prevalence rate in India as compared to the world, having only few but expensive treatment options. The triggers of Mucor infection in Covid-19 patients are immune deficiency and hyperglycaemia caused by the use of corticosteroid, which favours Mucorales tissue Penetration. Mucormycosis has mainly six different types viz pulmonary, rhino-orbital-cerebral, gastrointestinal, widely disseminated, cutaneous, & miscellaneous infection, the commonest clinical presentation is rhino-orbito-cerebral in Covid-19 pandemic.

Ayurveda though an ancient science of healing, has strength to treat newer diseases from several decades. Mucormycosis disease is not mentioned in Ayurveda text directly, it is Un uttered disease (Anukta Vyadhi) but it can be treated with help of basic principles of Ayurveda. By understanding the pathogenesis, it can be stated that, it is an Abhishangaja Vyadhi   (diseased caused by Virus/ Bacteria/ Parasite) and categorised as Raktapitta Pradhan Tridoshaja Vyadhi (disease caused by vitiation of all three humors with rakta pitta predominance).

Prevention of Mucormycosis can be achieved by following daily (Dincharya) and seasonal (Ritucharya) regimens. The treatment protocol include Krimighna (Antimicrobial),  Tridoshashamak (normalise all three humors) and Raktashodhaka /Pittashamak (blood purifier), Agnideepak (improve digestion) & Aampachak (improve metabolism), Pramehhar (treatment of diabetes/hyperglycaemia) and Rasayana (Rejuvenation) drugs.

 

Key words- Abhishangaj vyadhi, Anukta Vyadhi, Mucormycosis , RaktaPitta Pradhan Tridoshaj Vyadhi

Author Biographies

Anupama M Bathe

PhD Scholar, Assistant Professor, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurveda & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra.

Harsha Thanvi

PhD Scholar, Assistant Professor, Department of Dravyagun Vigyan, Dr. D. Y. Patil College of Ayurveda & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra.

Digambar Dipankar

Professor, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurveda & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra.

Leena Jungade

Assistant Professor, Department of Rachana Sharir, Dr. D. Y. Patil College of Ayurveda & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra.

Jibi Varghese

Professor, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurveda & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra.

Pallavi Mane

PhD Scholar, Assistant Professor, Department of Kayachikitsa, Dr. D. Y. Patil College of Ayurveda & Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra. 

Downloads

Published

08-07-2022

How to Cite

Bathe, A. M., Thanvi, H. ., Dipankar, D., Jungade, L., Varghese, J., & Mane, P. (2022). Understanding of Post Covid Mucormycosis through the Lens of Ayurveda. International Journal of Ayurvedic Medicine, 13(2), 268–273. https://doi.org/10.47552/ijam.v13i2.2659

Issue

Vol. 13 No. 2 (2022): April-June 2022

Section

Review Articles

License

Copyright (c) 2022 International Journal of Ayurvedic Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.

This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.

The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

http://creativecommons.org/licenses/by/3.0/